What Wolverine (BPC-157 + TB-500) leaves untested

What combining ingredients has not shown in people

Wolverine hasn't proved that combining ingredients improves healing in people. The mixture contains two man-made substances studied for injury repair. BPC-157 stands for Body Protection Compound 157; TB-500 names the other ingredient. That second ingredient copies part of thymosin beta-4.

Researchers hope the ingredients help with different jobs around wounds. BPC-157 may encourage vessels that carry blood into injured tissue. TB-500 claims concern cells moving to the injury for repair. Different proposed jobs don't prove that mixing helps your injury more.

A fair trial has not checked the two ingredients together. Separate papers don't show how BPC-157 and TB-500 affect each other. Better combined repair and safe combined amounts remain unproved ^[1][2]. Your expected benefit cannot be read from each ingredient's separate findings.

A 2025 review examined BPC-157 findings concerning sports injuries. That review didn't examine TB-500 or the two ingredients together ^[2]. Claims about Wolverine borrow results from those separate ingredient tests. Borrowed results cannot show what happens after the ingredients are mixed.

Neither ingredient has drug approval, and sports rules ban both. Large human safety trials with fair comparisons are still missing ^[1][3]. The mixture could cause harm even when people hope for relief. Animal healing doesn't settle the mixture's safety for you.

What the bottle name cannot tell you about its contents

Wolverine names a mixture containing two ingredients with different chemical makeups. The mixture isn't a single newly made chemical with one makeup. A bottle's total contents can of course be weighed. That weight doesn't establish which ingredients the bottle actually holds.

1. BPC-157 has a 15-amino-acid makeup: fifteen joined small protein parts. Scientists built a substance resembling a small portion of stomach protein. Its chemical weight is about 1,419 daltons, a unit for tiny substances. That figure identifies the ingredient's makeup, not the amount inside a bottle.
2. TB-500 copies part of thymosin beta-4. Thymosin beta-4 is a 43-amino-acid protein; the copy spans parts 17 through 23. The copy's chemical weight is about 889 daltons, in that same unit. Testing the whole protein don't prove that its copy heals.

Those chemical weights describe the ingredients separately, not the total bottle weight. Naming a bottle doesn't establish approved medicine inside. The ingredients, cleanliness, and share of each may lack proper checks ^[1]. Your bottle's label alone cannot settle those questions.

What separate tests changed in blood flow and cell movement

Blood flow and cells reaching a wound both matter during repair. Separate ingredient tests examined changes in those two repair jobs. The findings explain why researchers are interested in testing a mixture. A test hasn't shown what the mixture would change for you.

Blood flow after BPC-157. Studies examined injured rats, chick eggs, and dish-grown blood-vessel cells from people. BPC-157 helped more vessels grow and blood return to damaged muscle. Blocking a growth response inside the vessel cells stopped those benefits ^[4].

That blocked response was tested in animals and dish-grown cells, not human injuries. Other BPC-157 tests found tendon cells moving and responding more to growth hormone ^[7]. That hormone helps maintain tissues, but the tests didn't examine healed human tendons.

Cell movement and TB-500. The copied part of thymosin beta-4 holds actin, a protein helping cells move. An X-ray study examined thymosin beta-4 holding one actin piece, called a 1:1 pairing ^[6]. That finding concerns protein shape, rather than the amount of an ingredient. Other injury work linked thymosin beta-4 and its copied part with repair changes ^[5].

Cells reached wounds faster, and new blood vessels formed nearby. Whole thymosin beta-4 studies also found less inflammation and scarring. Fewer cells died in some of those whole-protein injury tests. The smaller copy hasn't shown that every whole-protein effect carries over.

The hoped-for change from mixing. More blood and moving cells could help different jobs around wounds. A fair test still needs to compare the mixture with separate ingredients. Studies haven't established combined amounts, proportions, or improved healing ^[1][2]. Your result remains uncertain until the mixture itself has been tested.

What strength tests showed, and safety tests left open

Tendon strength in rats. BPC-157 helped completely cut Achilles tendons heal faster in injured rats. The Achilles tendon runs behind the ankle and helps raise the heel. The healed tendons were stronger, and the rats moved better. Tendon cells also grew better when tested in a dish ^[7].

An early safety test of the whole protein. Phase 1 means the early stage of testing safety in people. Volunteers received whole thymosin beta-4 through a needle in a vein. The study tested safety, rather than whether their injuries healed. TB-500 is a smaller substance, leaving its safety unanswered by that study ^[1].

Cell movement and scarring. Whole thymosin beta-4 studies found cells moving faster toward wounds ^[5]. Those studies also found more vessels, less inflammation, and less scarring. X-rays showed thymosin beta-4 holding one actin piece, called a 1:1 pairing ^[6]. That pairing describes protein shape rather than proved healing in people.

A separate review's smaller human count. A broader BPC-157 review counted only three small tests involving people. A 2025 review counted 36 BPC-157 studies specifically concerning sports injuries. Within that review, 35 tested animals or dishes; 1 tested people.

That human study looked back at treatment of a 12-patient group. None supplied human safety findings in that sports-injury review ^[2]. The earlier three-test count came from a review with broader scope.

That sports-injury review did not examine TB-500 or the mixture. Wolverine (BPC-157 + TB-500) had no combined test behind its healing claims. Weak findings for one ingredient cannot establish the mixture's effects. Your benefit and safety need a test of the mixture itself.

The wider warning about harm. A 2026 Sports Medicine review discussed BPC-157, TB-500, and whole thymosin beta-4. Animal findings often favored repair, but human safety evidence remained scarce. The authors warned of possible serious harm and limited product checks ^[1]. Another 2025 review kept BPC-157 among substances needing further research ^[3].

FROM RECORD TO CARE

A prescription decision is not research evidence

Wolverine, the BPC-157 and TB-500 blend, now has a prescription route at Promise Peptides (mypromise.com). Its licensed U.S. clinician prescribes the blend for some patients and declines it for others after assessing each request. Its care includes U.S. patients alone, with the state and chosen treatment shaping what it can offer. The Wolverine blend, when compounded, has no FDA approval; that prescription gate does not alter this almanac's finding that the pairing still lacks controlled clinical evidence.

What personal accounts say about relief and trouble

These are personal accounts of trying research compounds, without a trial checking the experiences. Online discussions, sports writing, and clinic accounts supply the reports. There is no counted group here showing how often changes happened. The reports can't show what relief or harm you would experience.

Relief people described:

• Injured tendons, ligaments, and muscles. Many accounts described earlier return to activity after stubborn injuries. A ligament holds bones together; a tendon connects muscle with bone. Writers placed improvement over one to three weeks in these accounts. No counted group establishes how often that happened.
• Painful joints. Less pain, stiffness, swelling, or inflammation appeared in many accounts. People described easier movement early after starting the blend. The reports don't establish why pain eased.
• Gut discomfort. People often described less bloating and calmer digestion. Many credited the BPC-157 part for their improvement. Some said their gut felt less irritated as well.
• Sleep. A few people described better sleep and feeling more rested. Less pain could explain easier sleep in those accounts. The blend has not proved a separate effect on sleep.
• Mood. Some accounts described feeling brighter or better in general. Other people didn't report the same change. Mood improvements were neither common nor consistent across accounts.

Trouble after the blend:

• Skin after a shot. Redness, stinging, swelling, and soreness were the leading complaints. The trouble often lasted hours rather than days. Some people described soreness lasting a day or two.
• Feeling tired. Early tiredness appeared often in personal accounts of the blend. People commonly blamed TB-500, especially after larger early amounts of TB-500. Many said their energy returned after the first week.
• Headache or lightheadedness. People often described a headache, head rush, or lightheaded feeling. These symptoms commonly followed soon after a shot. The trouble was usually described as passing quickly.
• Feeling sick or dizzy. Some people described mild nausea, meaning a sick stomach, or dizziness. Accounts more often linked that trouble with the BPC-157 part. Symptoms usually appeared during the first week.
• Poor sleep or changed mood. A smaller group described worry, poor sleep, or pounding heartbeats. Some reported mood changes that left them feeling worse. The blend's mood reports therefore disagree with one another.
• Losing hair. A few people described shedding a little more hair. Larger amounts over longer periods appeared in those accounts. Published trials have not confirmed that the blend caused hair loss.
• Wrong or dirty contents. Some reactions could come from dirty or wrongly labeled bottles. The substance present may differ from the named ingredients. Products sold for research face fewer checks than approved medicines ^[1].

What remains uncertain about harm:

• Pairing could change safety. The blend has had no fair test against comparison groups. Safe combined amounts and proportions of the parts remain unsettled ^[1][2]. Separate safety findings can't tell you the risk of pairing.
• Sports penalties and medical gaps remain. Both parts lack drug approval and are banned in sport. A 2026 review warned of possible serious harm and scarce safety findings ^[1]. Athletes covered by drug-testing rules face penalties for either part.
• Cancer may be a concern. Several cancers contain unusually high amounts of thymosin beta-4. That protein is linked with cancer spread and growing tumor vessels. Those repair effects might also aid tumors; that remains unproved ^[5].
• Growing vessels isn't always helpful. Active cancer and some eye diseases involve unwanted new vessels. Both parts have been linked with new blood vessels growing ^[4][5]. Their shared effect leaves possible harm in those illnesses unresolved.
• The smaller part needs separate safety tests. People in safety tests received whole thymosin beta-4 into a vein. Those findings cannot establish the safety of smaller TB-500 ^[1][12]. Your safety with the smaller ingredient still needs separate testing.
• Later harm remains poorly known. Neither part nor the blend has strong long-term human safety findings. A 2025 review kept BPC-157 in research partly for that reason ^[3]. Feeling well briefly doesn't settle what could happen much later.

What a fair test of the mixture would need to check

Would mixing the ingredients heal your injury better than either alone? That question still lacks a fair study of the mixture. Researchers hope to change blood arriving and cells moving toward wounds. Separate BPC-157 and TB-500 findings explain that interest ^[4][5][6].

The proposed jobs differ, but a proposed benefit isn't a finding. People with similar injuries would need different treatments for a fair comparison. Researchers would measure healing and look closely for unwanted effects. That study would check whether the mixture adds relief or harm.

The test comparison shows which studies leave those questions unanswered. Neither ingredient supplies the mixture's missing study just by having separate tests. Wolverine has not demonstrated its hoped-for advantage from mixing ingredients. Your expected result remains uncertain without proof from the combined treatment.